BIOTECH TARGET N V - 26 Jul 2021 Form 4 Insider Report for Molecular Templates, Inc.

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Issuer symbol: N/A
Transactions as of: 26 Jul 2021
Net transactions value: +$1,091,656
Form type: 4
Filing time: 28 Jul 2021, 12:23:23 UTC
Previous filing: 21 Jul 2021
Next filing: 20 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MTEM	Common Stock	Purchase	$559,816	+80,000	+0.82%	$7.00^*	9,867,003	26 Jul 2021	Direct
transaction	MTEM	Common Stock	Purchase	$531,840	+75,000	+0.76%	$7.09^*	9,942,003	27 Jul 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.